PROCEPT BioRobotics Corp (PRCT)
68.16
+0.02
(+0.03%)
USD |
NASDAQ |
May 17, 16:00
65.00
-3.16
(-4.64%)
After-Hours: 20:00
PROCEPT BioRobotics Enterprise Value: 3.328B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 3.328B |
May 16, 2024 | 3.330B |
May 15, 2024 | 3.384B |
May 14, 2024 | 3.184B |
May 13, 2024 | 3.091B |
May 10, 2024 | 3.048B |
May 09, 2024 | 3.066B |
May 08, 2024 | 2.930B |
May 07, 2024 | 3.055B |
May 06, 2024 | 2.985B |
May 03, 2024 | 3.133B |
May 02, 2024 | 3.001B |
May 01, 2024 | 2.943B |
April 30, 2024 | 2.550B |
April 29, 2024 | 2.502B |
April 26, 2024 | 2.490B |
April 25, 2024 | 2.513B |
April 24, 2024 | 2.523B |
April 23, 2024 | 2.589B |
April 22, 2024 | 2.457B |
April 19, 2024 | 2.406B |
April 18, 2024 | 2.451B |
April 17, 2024 | 2.488B |
April 16, 2024 | 2.498B |
April 15, 2024 | 2.427B |
Date | Value |
---|---|
April 12, 2024 | 2.432B |
April 11, 2024 | 2.566B |
April 10, 2024 | 2.510B |
April 09, 2024 | 2.481B |
April 08, 2024 | 2.365B |
April 05, 2024 | 2.244B |
April 04, 2024 | 2.176B |
April 03, 2024 | 2.218B |
April 02, 2024 | 2.219B |
April 01, 2024 | 2.241B |
March 31, 2024 | 2.366B |
March 28, 2024 | 2.313B |
March 27, 2024 | 2.283B |
March 26, 2024 | 2.160B |
March 25, 2024 | 2.190B |
March 22, 2024 | 2.224B |
March 21, 2024 | 2.281B |
March 20, 2024 | 2.267B |
March 19, 2024 | 2.345B |
March 18, 2024 | 2.276B |
March 15, 2024 | 2.220B |
March 14, 2024 | 2.225B |
March 13, 2024 | 2.352B |
March 12, 2024 | 2.274B |
March 11, 2024 | 2.255B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
483.37M
Minimum
Jan 27 2022
3.384B
Maximum
May 15 2024
1.545B
Average
1.514B
Median
Feb 17 2023
Enterprise Value Benchmarks
Intuitive Surgical Inc | 136.75B |
Integra Lifesciences Holdings Corp | 1.507B |
Masimo Corp | 7.314B |
Perspective Therapeutics Inc | 817.27M |
Xtant Medical Holdings Inc | 116.32M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -25.96M |
Revenue (Quarterly) | 44.54M |
Total Expenses (Quarterly) | 72.19M |
EPS Diluted (Quarterly) | -0.51 |
Gross Profit Margin (Quarterly) | 56.21% |
Profit Margin (Quarterly) | -58.28% |
Earnings Yield | -3.11% |
Normalized Earnings Yield | -3.113 |